TransMedics Group, Inc.
TMDX
$146.31
$0.560.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 143.82M | 157.37M | 143.54M | 121.62M | 108.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 143.82M | 157.37M | 143.54M | 121.62M | 108.76M |
| Cost of Revenue | 59.25M | 60.78M | 55.31M | 49.61M | 47.92M |
| Gross Profit | 84.58M | 96.59M | 88.23M | 72.01M | 60.85M |
| SG&A Expenses | 46.02M | 44.09M | 43.63M | 46.91M | 42.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 120.52M | 120.80M | 116.09M | 112.98M | 104.84M |
| Operating Income | 23.30M | 36.57M | 27.44M | 8.64M | 3.92M |
| Income Before Tax | 23.03M | 36.18M | 26.68M | 6.99M | 4.25M |
| Income Tax Expenses | -1.29M | 1.28M | 994.00K | 132.00K | 29.00K |
| Earnings from Continuing Operations | 24.32M | 34.91M | 25.68M | 6.86M | 4.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.32M | 34.91M | 25.68M | 6.86M | 4.22M |
| EBIT | 23.30M | 36.57M | 27.44M | 8.64M | 3.92M |
| EBITDA | 29.35M | 43.30M | 33.58M | 14.32M | 9.10M |
| EPS Basic | 0.71 | 1.03 | 0.76 | 0.20 | 0.13 |
| Normalized Basic EPS | 0.42 | 0.67 | 0.49 | 0.13 | 0.08 |
| EPS Diluted | 0.66 | 0.92 | 0.70 | 0.20 | 0.12 |
| Normalized Diluted EPS | 0.35 | 0.56 | 0.42 | 0.12 | 0.07 |
| Average Basic Shares Outstanding | 34.11M | 33.91M | 33.72M | 33.59M | 33.44M |
| Average Diluted Shares Outstanding | 40.75M | 40.56M | 39.91M | 35.21M | 35.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |